Golden
OrbiMed

OrbiMed

U.S-based venture capital and private equity firm investing on life sciences companies worldwide.

All edits

Edits a day ago
Neelam Jhaveri
Neelam Jhaveri edited a day ago
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 13 Aug 2019
Neelam Jhaveri
Neelam Jhaveri edited on 13 Aug 2019 8:19 am
Edits made to:
Infobox (+1 properties)
Article

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

...

OrbiMed focuses on funding companies in the field of life sciences. The firm invests globally, with past investments on companies based in North America, Europe, and Asia (China, India, and Israel). The firm finances companies at various stages of development, from seed to buyouts. Its most recent funding round raised $551 million on September 2017.

Infobox

Edits on 25 Apr 2019
Golden AI
Golden AI edited on 25 Apr 2019 12:53 am
Edits made to:
Infobox (+1 properties)

Infobox

Industry
Edits on 15 Apr 2019
Golden AI
Golden AI edited on 15 Apr 2019 9:08 am
Edits made to:
Infobox (-1 properties)
Edits on 4 Apr 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 4 Apr 2019 9:32 pm
Edits made to:
Article (+20/-20 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firmventure capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Edits on 3 Apr 2019
Golden AI
Golden AI edited on 3 Apr 2019 11:49 am
Edits made to:
Infobox (+1 properties)
Edits on 22 Mar 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 22 Mar 2019 4:52 pm
Edits made to:
Article (+5/-5 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for ImaraImara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Edits on 21 Mar 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 21 Mar 2019 12:21 am
Edits made to:
Article (+6/-6 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; Shanghai, China; Herzliya, IsraelIsrael and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Edits on 19 Mar 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 19 Mar 2019 10:46 pm
Edits made to:
Article (+6/-6 characters)

Article

OrbiMed focuses on funding companies in the field of life sciences. The firm invests globally, with past investments on companies based in North America, EuropeEurope, and Asia (China, India, and Israel). The firm finances companies at various stages of development, from seed to buyouts. Its most recent funding round raised $551 million on September 2017.

Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 19 Mar 2019 10:45 pm
Edits made to:
Article (+5/-5 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, IndiaIndia; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 19 Mar 2019 6:24 pm
Edits made to:
Article (+10/-10 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, CaliforniaCalifornia; Mumbai, India; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 19 Mar 2019 6:15 pm
Edits made to:
Article (+5/-5 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; Shanghai, ChinaChina; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 19 Mar 2019 2:03 pm
Edits made to:
Article (+8/-8 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; ShanghaiShanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 19 Mar 2019 2:03 pm
Edits made to:
Article (+13/-13 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San FranciscoSan Francisco, California; Mumbai, India; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 19 Mar 2019 2:03 pm
Edits made to:
Article (+13/-13 characters)

Article

OrbiMed focuses on funding companies in the field of life sciences. The firm invests globally, with past investments on companies based in North AmericaNorth America, Europe, and Asia (China, India, and Israel). The firm finances companies at various stages of development, from seed to buyouts. Its most recent funding round raised $551 million on September 2017.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 19 Mar 2019 2:03 pm
Edits made to:
Article (+4/-4 characters)

Article

OrbiMed focuses on funding companies in the field of life sciences. The firm invests globally, with past investments on companies based in North America, Europe, and AsiaAsia (China, India, and Israel). The firm finances companies at various stages of development, from seed to buyouts. Its most recent funding round raised $551 million on September 2017.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 19 Mar 2019 2:03 pm
Edits made to:
Article (+9/-9 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; Shanghai, China; Herzliya, Israel and Hong KongHong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 19 Mar 2019 2:03 pm
Edits made to:
Article (+6/-6 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; MumbaiMumbai, India; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 19 Mar 2019 2:03 pm
Edits made to:
Article (+8/-8 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; Shanghai, China; HerzliyaHerzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Khadidiatou Amirou
Khadidiatou Amirou edited on 19 Mar 2019 2:01 pm
Edits made to:
Infobox (+1 properties)
Description (+97/-149 characters)
Article (+956 characters)
Categories (+1 topics)
Topic thumbnail

OrbiMed

OrbiMed is a healthcare management fund specializing in biopharmaceuticals that is Headquartered in New York City, New York and was founded in 1989.

U.S-based venture capital and private equity firm investing on life sciences companies worldwide.

Article



OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Funding

OrbiMed focuses on funding companies in the field of life sciences. The firm invests globally, with past investments on companies based in North America, Europe, and Asia (China, India, and Israel). The firm finances companies at various stages of development, from seed to buyouts. Its most recent funding round raised $551 million on September 2017.

Infobox

Categories